NCT04601090View on ClinicalTrials.gov

Survival Rates and Longterm Outcomes After COVID-19

CompletedOBSERVATIONAL
Enrollment

860

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

July 10, 2022

Conditions
Covid19Acute Respiratory FailureAcute Respiratory Distress SyndromePost Intensive Care Unit SyndromeSurvivorship
Interventions
OTHER

ICU treatment

This is an observational study, so all patients will undergo a variation of ICU treatment, and we will record that information (e.g., time on ventilator, time in ICU, SAPS score at admission)

Trial Locations (1)

0027

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

The Research Council of Norway

OTHER

lead

Oslo University Hospital

OTHER

NCT04601090 - Survival Rates and Longterm Outcomes After COVID-19 | Biotech Hunter | Biotech Hunter